News by topic

Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Hepatitis and HIV news

Show

From To
Hepatitis C treatment
HCV patients may be able to delay therapy

Hepatitis C patients without significant fibrosis may be able to delay triple therapy and wait for simpler, shorter, and potentially all-oral regimens that are currently under investigation, researchers said here.

Published
23 May 2012
From
MedPage Today
Hepatitis and HIV
Body-Building Supplements Top List of Hepatotoxic Agents

Supplements used for body-building and weight loss were the most frequent cause of liver injury related to herbal or dietary supplements in a review of the 8-center US Drug-Induced Liver Injury Network (DILIN).

Published
23 May 2012
From
Medscape (requires registration)
Hepatitis C symptoms and diagnosis
Hepatitis C Causing Liver Damage in Greater Numbers: Study

Hundreds of thousands of Americans infected with chronic hepatitis C virus could develop potentially life-threatening liver complications over the next few years, according to a new study. An additional 300,000 Americans could develop advanced liver disease from the virus by 2015

Published
23 May 2012
From
Health Day News
Hepatitis C symptoms and diagnosis
CDC recommends hepatitis C tests for all baby boomers

The federal government Friday called for all baby boomers to be tested for hepatitis C, which kills more Americans each year than AIDS and is the leading reason for liver transplants.

Published
20 May 2012
From
Washington Post
New and experimental hepatitis C treatment
Incivek Rash Reports: What HIV/Hepatitis C-Coinfected People Need to Know

It turns out that Incivek (telaprevir), one of the HCV protease inhibitors approved last year, is also associated with rash. About half of patients who take Incivek get a rash. It can sometimes be itchy, too. Most of the time the rash is mild or moderate.

Published
18 May 2012
From
The Body
Hepatitis C symptoms and diagnosis
Hepatitis C testing rate low and knowledge of the infection poor in the US "baby boomer" generation

Only a quarter of US individuals in the generation most likely to have hepatitis C have ever been tested for the infection, results of a survey conducted

Published
18 May 2012
By
Michael Carter
Hepatitis C treatment
Standard hepatitis C therapy improves insulin resistance in HIV/hepatitis C co-infected patients

Treatment with pegylated interferon and ribavirin is associated with lasting improvements in insulin resistance among HIV-positive people co-infected with hepatitis C, investigators report in the online edition of

Published
16 May 2012
By
Michael Carter
New and experimental hepatitis C treatment
BI 201335 & BI 207127 and ribavirin shows good efficacy, including hepatitis C patients with cirrhosis

An interferon-free regimen of the hepatitis C virus (HCV) protease inhibitor BI 201335, the non-nucleoside polymerase inhibitor BI 207127, and ribavirin produced sustained virological response in 68% of

Published
15 May 2012
By
Liz Highleyman
Hepatitis C treatment
Ribavirin dose reduction is effective for managing anaemia in patients using boceprevir or telaprevir

Reducing the dose of ribavirin and adding erythropoietin are both good options for managing anaemia in hepatitis C patients treated with boceprevir (Victrelis) triple therapy, according to

Published
11 May 2012
By
Liz Highleyman
Hepatitis C treatment
Depression and pegylated interferon: doctors look at screening strategies and treatment

Patients with hepatitis C should be carefully evaluated for symptoms of depression before and during pegylated interferon-based therapy, investigators write in the International Journal of Interferon, Cytokine and

Published
09 May 2012
By
Michael Carter
← First12345...50Next →

Filter by country